Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Karen Fairhurst Department of Community
Health Sciences (General Practice), University of Edinburgh, Levinson
House, Edinburgh EH8 9DX
Correspondence to: Dr Fairhurst Karen.Fairhurst{at}ed.ac.uk
Objectives To explore how general practitioners have
accessed and evaluated evidence from trials on the use of statin lipid
lowering drugs and incorporated this evidence into their practice. To
draw out the practical implications of this study for strategies to
integrate clinical evidence into general medical practice.
Design Qualitative analysis of semistructured
interviews.
Setting General practices in Lothian.
Subjects 24 general practitioners selected to obtain
a heterogeneous sample.
Results Respondents were generally aware of the
evidence relating to the use of statins in secondary prevention of coronary heart disease, but they were less clear about the evidence in
primary prevention. The benefits of statins in secondary prevention were clearer to them and the social and economic issues less complex than was the case for use in primary prevention. Respondents rarely said they appraised the methods and content of trials, rather they
judged the trustworthiness of the source of trial evidence and
interpreted it within the context of the economic and social factors
which impinge on their practice. Moreover, trial data become relevant
for routine practice only when underpinned by a consensus on these
issues.
Conclusion Strategies to promote incorporation of
evidence from clinical trials into everyday practice are likely to be
effective if they tap into and build on the process of local consensus
building. Strategies such as teaching critical appraisal skills and
guideline development may have little effect if they are separated from
this process.
Key messages
for example, appraisal and clinical guidelines
may fail if
they are based on unrealistic models of how evidence is assessed
© BMJ 1998
Read all Rapid Responses